ThermoGenesis Holdings To Delay Second Quarter 2020 Earnings Release And Conference Call Until Friday August 14, 2020
ThermoGenesis Holdings, Inc. (THMO) announced a delay in its second quarter earnings release, originally scheduled for August 12, 2020. The new date for the release is set for August 14, 2020, after market close. Following this, a conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET. This delay comes as ThermoGenesis continues to focus on its automated technologies for CAR-T therapies and other cell-based treatments.
- None.
- Delay of second quarter earnings release may signal underlying issues.
RANCHO CORDOVA, Calif., Aug. 11, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced it will delay its second quarter earnings release and conference call for the quarter ended June 30, 2020, previously scheduled for Wednesday, August 12, 2020. The Company now intends to report its second quarter 2020 results on Friday, August 14, 2020, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.
To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.
A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.
Company Contact:
Wendy Samford
916-858-5191
ir@thermogenesis.com
Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-delay-second-quarter-2020-earnings-release-and-conference-call-until-friday-august-14-2020-301110326.html
SOURCE ThermoGenesis Holdings, Inc.
FAQ
When will ThermoGenesis Holdings report its Q2 2020 earnings?
What time is the ThermoGenesis earnings conference call?
What is the significance of the THMO earnings delay?
